136 related articles for article (PubMed ID: 38821688)
21. Allopurinol hepatotoxicity. Case report and literature review.
Chawla SK; Patel HD; Parrino GR; Soterakis J; Lopresti PA; D'Angelo WA
Arthritis Rheum; 1977; 20(8):1546-9. PubMed ID: 921828
[TBL] [Abstract][Full Text] [Related]
22. Primary prophylaxis of variceal bleeding in liver cirrhosis: failure to learn from past experience.
Shah SK; Desai HG
Indian J Gastroenterol; 2001; 20(2):64-7. PubMed ID: 11305494
[TBL] [Abstract][Full Text] [Related]
23. Allopurinol-induced hepatomegaly.
Childs L; Dow C
BMJ Case Rep; 2012 Oct; 2012():. PubMed ID: 23087287
[TBL] [Abstract][Full Text] [Related]
24. Prophylaxis of idiopathic and gouty uric acid lithiasis by allopurinol.
de Vries A; Frank M
Urol Int; 1967; 22(6):506-16. PubMed ID: 5590840
[No Abstract] [Full Text] [Related]
25. D-Allose has a strong suppressive effect against ischemia/reperfusion injury: a comparative study with allopurinol and superoxide dismutase.
Hossain MA; Izuishi K; Tokuda M; Izumori K; Maeta H
J Hepatobiliary Pancreat Surg; 2004; 11(3):181-9. PubMed ID: 15235891
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Oesophageal Varices in Liver Cirrhosis.
Sauerbruch T; Wong F
Digestion; 2019; 99(4):261-266. PubMed ID: 30212817
[TBL] [Abstract][Full Text] [Related]
27. Cirrhosis and chronic liver failure: part II. Complications and treatment.
Heidelbaugh JJ; Sherbondy M
Am Fam Physician; 2006 Sep; 74(5):767-76. PubMed ID: 16970020
[TBL] [Abstract][Full Text] [Related]
28. Effects of antioxidant agents against cyclosporine-induced hepatotoxicity.
Akbulut S; Elbe H; Eris C; Dogan Z; Toprak G; Yalcin E; Otan E; Turkoz Y
J Surg Res; 2015 Feb; 193(2):658-66. PubMed ID: 25281288
[TBL] [Abstract][Full Text] [Related]
29. Suboptimal use of pharmacological venous thromboembolism prophylaxis in cirrhotic patients.
Yang LS; Alukaidey S; Croucher K; Dowling D
Intern Med J; 2018 Sep; 48(9):1056-1063. PubMed ID: 29468795
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic prophylaxis in cirrhosis: Good and bad.
Fernández J; Tandon P; Mensa J; Garcia-Tsao G
Hepatology; 2016 Jun; 63(6):2019-31. PubMed ID: 26528864
[TBL] [Abstract][Full Text] [Related]
31. Does starting allopurinol prolong acute treated gout? A randomized clinical trial.
Hill EM; Sky K; Sit M; Collamer A; Higgs J
J Clin Rheumatol; 2015 Apr; 21(3):120-5. PubMed ID: 25807090
[TBL] [Abstract][Full Text] [Related]
32. [Antibiotic prophylaxis in liver cirrhosis].
Restellini S; Nendaz M; Morard I
Rev Med Suisse; 2012 Feb; 8(326):276, 278-81. PubMed ID: 22364077
[TBL] [Abstract][Full Text] [Related]
33. Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study.
Fayed A; Hammad AA; Abdulazim DO; Hammad H; Amin M; Elhadidy S; Salem MM; ElAzim IMA; Zsom L; Csongradi E; Soliman KM; Sharaf El Din UA
Ren Fail; 2023 Dec; 45(1):2194434. PubMed ID: 36974638
[TBL] [Abstract][Full Text] [Related]
34. Complications of cirrhosis. Why they occur and what to do about them.
McGuire BM; Bloomer JR
Postgrad Med; 1998 Feb; 103(2):209-12, 217-8, 223-4. PubMed ID: 9479317
[TBL] [Abstract][Full Text] [Related]
35. [Alcoholic liver cirrhosis; treatment of complications].
AUBERTIN E
J Med Bord; 1956 Feb; 133(2):169-70. PubMed ID: 13319959
[No Abstract] [Full Text] [Related]
36. Quercetin and allopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipid accumulation in diabetic rats.
Wang W; Wang C; Ding XQ; Pan Y; Gu TT; Wang MX; Liu YL; Wang FM; Wang SJ; Kong LD
Br J Pharmacol; 2013 Jul; 169(6):1352-71. PubMed ID: 23647015
[TBL] [Abstract][Full Text] [Related]
37. Preventing acute gout when starting allopurinol therapy. Colchicine or NSAIDs?
Kot TV; Day RO; Brooks PM
Med J Aust; 1993 Aug; 159(3):182-4. PubMed ID: 8336619
[TBL] [Abstract][Full Text] [Related]
38. Drug dosage protocol for calcium oxalate stone.
Marickar YM; Salim A
Urol Res; 2009 Dec; 37(6):353-7. PubMed ID: 19826800
[TBL] [Abstract][Full Text] [Related]
39. Comments on the review article: Ascites in cirrhosis: a review of management and complications.
Koulaouzidis A; Bhat S
Neth J Med; 2008 Apr; 66(4):177; author reply 178. PubMed ID: 18424869
[No Abstract] [Full Text] [Related]
40. Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout.
Feher MD; Hepburn AL; Hogarth MB; Ball SG; Kaye SA
Rheumatology (Oxford); 2003 Feb; 42(2):321-5. PubMed ID: 12595630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
